Tekturna and Reglan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tekturna (aliskiren hemifumarate) and Reglan (metoclopramide hydrochloride). Common drug interactions include chronic kidney disease among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Tekturna and Reglan. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Tekturna?

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.

On Jul, 10, 2026

14 people who take Tekturna and Reglan together, and have interactions are studied.

What are the common drug interactions of Tekturna and Reglan, by gender? *:

female:

Chronic kidney disease
Renal failure (kidney dysfunction)
Anaemia (lack of blood)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Anxiety
Asthenia (weakness)
Blood chloride decreased
Blood glucose increased
Depression
Dyspnoea (difficult or laboured respiration)

male:

Cardiac failure congestive
Dehydration (dryness resulting from the removal of water)
Gastric ulcer (stomach ulcer)
Gastritis (inflammation of stomach)
General physical health deterioration (weak health status)
Hypotension (abnormally low blood pressure)
Influenza
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Pneumonia
Vomiting

What are the common drug interactions of Tekturna and Reglan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Gastric ulcer (stomach ulcer)
Gastritis (inflammation of stomach)
Vomiting

30-39:

Chronic kidney disease
Nephropathy (damage to or disease of a kidney)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

40-49:

n/a

50-59:

n/a

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Headache (pain in head)
Heart rate increased
Hypokalaemia (low potassium)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Interstitial lung disease
Malaise (a feeling of general discomfort or uneasiness)
Mitral valve incompetence (inefficient heart valve)
Nephrogenic anaemia (anaemia due to kidney disease)

What are the existing conditions these people have? *

Pain: 3 people, 21.43%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 21.43%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 21.43%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 14.29%
Constipation: 2 people, 14.29%
Bacterial Infection: 2 people, 14.29%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.14%
Kidney Infection: 1 person, 7.14%
Hyperkalemia (damage to or disease of the kidney): 1 person, 7.14%
Blood Pressure Abnormal: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Tekturna and Reglan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously